AIN457
CAIN457C2301
Phase 3 mab terminated
Quick answer
AIN457 for Non-infectious Uveitis is a Phase 3 program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Non-infectious Uveitis
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated